The role of anti-mullerian hormone in determining ovarian reserve in patients with endometrioma and benign cysts

In: Zeynep Kamil Medical Journal · 2024 · pp. 29–33 · doi:10.14744/zkmj.2023.71084 · W4392824117
article OA: bronze CC0
AI-generated summary by claude@2026-06, 2026-06-08

This study measured pre- and postoperative Anti-Mullerian Hormone (AMH) levels to assess endometrioma's effect on ovarian reserve in patients with endometrioma and benign cysts.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective: Our aim was to determine the effects of endometrioma by itself and its surgery on ovarian reserve via pre-and postoperative serial measurements of Anti-Mullerian Hormone (AMH) in patients with endometrioma and benign cysts.

My notes (saved in your browser only)

Condition tags

endometrioma

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK